(Q35981167)

11 August 2017

1 reference

title

Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines (English)

1 reference

11 August 2017

Petra Ch Feyer

1

1 reference

11 August 2017

Ernesto Maranzano

2

1 reference

11 August 2017

Alexander Molassiotis

3

1 reference

11 August 2017

Rebecca A Clark-Snow

4

1 reference

11 August 2017

Fausto Roila

5

1 reference

11 August 2017

David Warr

6

1 reference

11 August 2017

Ian Olver

7

1 reference

11 August 2017

publication date

8 December 2004

1 reference

Supportive Care in Cancer

11 August 2017

published in

1 reference

11 August 2017

volume

13

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

122-128

1 reference

Nausea and vomiting in fractionated radiotherapy: A prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide

11 August 2017

cites work

1 reference

12 December 2020

Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation

1 reference

12 December 2020

Prevention of radiotherapy-induced emesis

1 reference

12 December 2020

The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy

1 reference

12 December 2020

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

12 December 2020

5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile

1 reference

12 December 2020

Ondansetron in the control of refractory emesis following radiotherapy

1 reference

12 December 2020

Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy

1 reference

12 December 2020

Prevention of radiotherapy-induced emesis

1 reference

12 December 2020

A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy

1 reference

12 December 2020

A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea

1 reference

12 December 2020

Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation.

1 reference

12 December 2020

Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy.

1 reference

12 December 2020

Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy

1 reference

12 December 2020

Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting

1 reference

12 December 2020

Granisetron in the prevention of irradiation-induced emesis

1 reference

12 December 2020

Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review

1 reference

12 December 2020

Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.

1 reference

12 December 2020

Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation

1 reference

12 December 2020

Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrati

1 reference

12 December 2020

Escalating dose of oral ondansetron in the prevention of radiation induced emesis

1 reference

12 December 2020

The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in stage I seminoma of the testis: a randomized pilot study

1 reference

12 December 2020

A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy

1 reference

12 December 2020

Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study.

1 reference

12 December 2020

Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC)

1 reference

12 December 2020

Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation

1 reference

12 December 2020

[The use of granisetron per os in radiotherapy-induced emesis]

1 reference

12 December 2020

10.1007/S00520-004-0705-3

Identifiers

DOI

1 reference

11 August 2017

1 reference